↓ Skip to main content

Dove Medical Press

Eating Disorders and the Use of Cognitive Enhancers and Psychostimulants Among University Students: A Cross-Sectional Study

Overview of attention for article published in Neuropsychiatric Disease and Treatment, May 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
72 Mendeley
Title
Eating Disorders and the Use of Cognitive Enhancers and Psychostimulants Among University Students: A Cross-Sectional Study
Published in
Neuropsychiatric Disease and Treatment, May 2021
DOI 10.2147/ndt.s308598
Pubmed ID
Authors

Basma Damiri, Omar A Safarini, Zaher Nazzal, Ahmad Abuhassan, Ahmad Farhoud, Nesma Ghanim, Rayyan Al Ali, Mirvat Suhail, Mohammad Qino, Mohammad Zamareh, Ammar Thabaleh, Jihad Zahran

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 72 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 8%
Student > Bachelor 5 7%
Student > Master 4 6%
Student > Doctoral Student 3 4%
Unspecified 3 4%
Other 9 13%
Unknown 42 58%
Readers by discipline Count As %
Medicine and Dentistry 10 14%
Nursing and Health Professions 6 8%
Unspecified 3 4%
Psychology 3 4%
Social Sciences 3 4%
Other 7 10%
Unknown 40 56%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 August 2021.
All research outputs
#15,181,325
of 25,387,668 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,420
of 3,131 outputs
Outputs of similar age
#223,981
of 453,943 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#22
of 55 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,131 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 52% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 453,943 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 55 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.